Lawyers warn against 'sofa rash'
Consumers across Wales could be entitled to compensation if they are aware of the symptoms of contact dermatitis, more commonly known as 'sofa rash'. Leo Abse & Cohen is campaigning to raise awareness of consumers' rights to claim for the pain and suffering caused by the condition, and is urging people to be aware of its symptoms which can include itching, burning, blistering or weeping skin and even breathing difficulties
Putting school support staff on top of the agenda
Mike Jenkins, one of our partners and committed trade unionist urges the Welsh Assembly Government to adopt Westminster's recently implemented National Pay and Conditions Framework for School Support Staff to improve the conditions for school support staff in Wales. Addressing the audience at the Wales TUC's annual conference in Llandudno, where around 300 delegates from across Wales met to debate issues concerning employers in Wales, Mike Jenkins highlighted the importance of school support staff in Welsh schools and the need to improve their terms and conditions
Yvonne Agnew, Clinical Negligence Practitioner and Partner at leading south Wales law firm, Leo Abse & Cohen is on the Legal Advice working group involved in making proposals to the Welsh Assembly Government about the way in which legal advice will be provided within the NHS Redress Measure. Here she looks in detail at what the Redress Bill will provide and asks, can we, in Wales, at last begin to hope for more open, patient orientated system of redress when things go wrong with our care
South-Wales law firm, Leo Abse & Cohen, has appointed a qualified Trusts and Estates Practitioner (TEP) to strengthen its wills and estates team. Julie Carvey will manage and develop the team's probate unit and promote a dedicated resource designed to support clients who are involved with estate administration
More News
No win no fee?
The myth behind 'free' care leaves NHS with potential £10 billion bill
Safety warning to young Welsh workers
Newport firm admits liability on first day of Q-Fever trial